Pulmonx Corporation
A maker of minimally invasive devices for people with severe emphysema and COPD, Pulmonx built its business around the Zephyr Endobronchial Valve, a tiny one-way implant placed through a bronchoscope to let trapped air escape from diseased lung lobes so healthier tissue can work. The company was founded in California in 1995 by Dr. Rodney Perkins. Its flagship product takes its name from the Greek word for a gentle west wind — a nod to helping patients breathe more easily.
Granted 1.51M · Sold 629.0K
Granted 1.38M · Sold 26.1K
Granted 416.4K · Sold 124.6K
Granted 476.4K · Sold 113.5K
Granted 387.0K · Bought 14.2K · Sold 47.3K
Granted 175.0K · Sold 25.0K
Granted 233.9K · Sold 30.4K
Granted 110.6K
Granted 110.6K
Granted 110.6K · Bought 23.3K · Sold 23.3K
Granted 110.6K · Bought 5.4K · Sold 8.0K
Granted 115.2K
Granted 110.6K
Granted 36.0K · Sold 942
Granted 22.8K · Bought 1.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| French Glendon E. IIIPresident and CEO, Director · 71 transactions | — | 2.10M | 1.51M | — | 629.0K |
| Sung DerrickCOO and CFO · 27 transactions | +460.6% | 1.34M | 1.38M | — | 26.1K |
| Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · 79 transactions | +175.6% | 460.0K | 416.4K | — | 124.6K |
| Lehman David AaronGENERAL COUNSEL · 63 transactions | +2085.3% | 384.6K | 476.4K | — | 113.5K |
| Williamson Steven S.PRESIDENT AND CEO, Director · 8 transactions | — | 363.5K | 387.0K | 14.2K | 47.3K |
| Radhakrishnan SrikanthChief Science &Techn. Officer · 9 transactions | — | 340.9K | 175.0K | — | 25.0K |
| Joshi MehulChief Financial Officer & PAO · 7 transactions | — | 208.5K | 233.9K | — | 30.4K |
| Mead Dana G Jr.Director · 5 transactions | +333.1% | 143.8K | 110.6K | — | — |
| Melenikiotou GeorgiaDirector · 5 transactions | +430.9% | 139.7K | 110.6K | — | — |
| Florin Daniel PDirector · 7 transactions | +1677.9% | 133.9K | 110.6K | 23.3K | 23.3K |
| Ferrari RichardDirector · 8 transactions | — | 127.0K | 110.6K | 5.4K | 8.0K |
| Sullivan TiffanyDirector · 6 transactions | — | 115.2K | 115.2K | — | — |
| Burns Thomas WilliamDirector · 5 transactions | +3935.6% | 113.4K | 110.6K | — | — |
| McKune JohnINTERIM CFO · 5 transactions | — | 76.2Kas of Mar 2024 | 36.0K | — | 942 |
| Lynch Alissa HsuDirector · 4 transactions | — | 24.5Kas of Jun 2023 | 22.8K | 1.7K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -983.4K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.